Johnson Midwest Financial’s Emergent Biosolutions EBS Stock Holding History

Johnson Midwest Financial’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$510	Hold	150	–	–	﹤0.01%	357
2023 Q2	$1.1K	Hold	150	–	–	﹤0.01%	339
2023 Q1	$1.55K	Buy	150 +50	+50%	+$604	﹤0.01%	340
2022 Q4	$1K	Hold	100	–	–	﹤0.01%	347
2022 Q3	$2	Hold	100	–	–	0.01%	287
2022 Q2	$3K	Hold	100	–	–	﹤0.01%	248
2022 Q1	$4K	Hold	100	–	–	0.01%	212
2021 Q4	$4K	Hold	100	–	–	﹤0.01%	219
2021 Q3	$5K	Hold	100	–	–	﹤0.01%	213
2021 Q2	$6K	Buy	+100	New	+$6.42K	0.01%	194

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Johnson Midwest Financial's EBS Position: Q3 2023 in Review

Johnson Midwest Financial held its Emergent Biosolutions (EBS) position steady in Q3 2023 at 150 shares worth $510. The position accounts for ﹤0.01% of the portfolio, ranked #357.

Johnson Midwest Financial first reported a position in EBS in Q2 2021 and has held it in 10 quarters since. The position peaked at $6K in Q2 2021. 162 funds tracked by Wall St. Rank hold EBS as of Q3 2023.

Johnson Midwest Financial held 150 shares of Emergent Biosolutions worth $510 as of Q3 2023.
Johnson Midwest Financial left its Emergent Biosolutions share count unchanged in Q3 2023.
Emergent Biosolutions made up ﹤0.01% of Johnson Midwest Financial's portfolio in Q3 2023, its #357 holding.
Johnson Midwest Financial first reported a position in Emergent Biosolutions in Q2 2021 and has held it in 10 quarters since.
Johnson Midwest Financial's Emergent Biosolutions position peaked at $6K in Q2 2021.
162 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2023.

Based on Johnson Midwest Financial's 13F filing for Q3 2023, filed 7 Nov 2023.